Eqrx, Inc. Announces CFO Changes
Accordingly, on March 9, 2023, EQRx's board of directors appointed Melanie Nallicheri, EQRx's President and Chief Executive Officer and principal executive officer, as principal financial officer, with immediate effect, and plans to conduct a search for a successor chief financial officer. Ms. Nallicheri, age 54, has been EQRx's President, Chief Executive Officer and member of the Board since December 2021 and is a co-founder of EQRx International, Inc. and was the President and Chief Operating Officer of EQRx International, Inc. since August 2019 and effective September 1, 2021 assumed the role of President and Chief Executive Officer and joined EQRx International, Inc.'s board of directors. Ms. Nallicheri is a healthcare and life sciences executive with nearly three decades of experience. Prior to joining EQRx International, Inc., from September 2016 to April 2019, Ms. Nallicheri served as Chief Business Officer and Head of Biopharma for Foundation Medicine, Inc. Prior to that, from 2013 to June 2016, Ms. Nallicheri served in a variety of roles at McKesson Corporation, including as Senior Vice President, Corporate Strategy and Business Development at McKesson Distribution Solutions and McKesson Data & Analytics; and prior thereto, from 2011 to 2013 as Senior Vice President, Corporate Development at Geron Corporation. Ms. Nallicheri holds an M.S. in business and economics from WHU Otto Beisheim School of Corporate Management in Koblenz, Germany and an M.B.A. with honors from Columbia Business School.